Filing Details

Accession Number:
0001593968-20-002243
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-24 16:09:50
Reporting Period:
2020-11-23
Accepted Time:
2020-11-24 16:09:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887359 Vericel Corp VCEL Biological Products, (No Disgnostic Substances) (2836) 943096597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1220363 Md L Robert Zerbe C/O Vericel Corporation
64 Sidney Street
Cambridge MA 02139
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-23 15,000 $3.74 34,295 No 4 M Direct
Common Stock Acquisiton 2020-11-23 15,000 $2.76 49,295 No 4 M Direct
Common Stock Disposition 2020-11-23 17,500 $23.55 31,795 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-11-23 15,000 $0.00 15,000 $3.74
Common Stock Stock Option (right to buy) Disposition 2020-11-23 15,000 $0.00 15,000 $2.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-03-20 No 4 M Direct
0 2026-05-04 No 4 M Direct
Footnotes
  1. These options, representing the right to purchase a total of 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015 and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.
  2. These options, representing the right to purchase a total of 15,000 shares, were originally granted on May 4, 2016, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.